Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
A consumer advocacy group warns that the FDA doesn’t have enough authority to protect patients from potentially dangerous medical devices as the Senate prepares to vote on a bill reauthorizing the fees medical device and drug makers pay for federal review.
The U.K.’s Medicines & Healthcare Products Regulatory Agency warns that even more women should be considered at risk of having received substandard breast implants made by Poly Implant Prosthèse.
Response Biomedical becomes the 2nd company in recent weeks to respond to SEC concerns about med-tech sales to countries deemed “state sponsors of terrorism,” finding that a few of its sales to Iran may have fallen under export controls.